KOP Limited (SGX:5I1)

Market Cap	48.75M
Revenue (ttm)	69.68M
Net Income (ttm)	-1.18M
Shares Out	1.11B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.00 (2.00%)
Ex-Dividend Date	Aug 1, 2025

Volume	422,200
Average Volume	3,010,950
Open	0.0450
Previous Close	0.0450
Day's Range	0.0430 - 0.0450
52-Week Range	0.0270 - 0.0530
Beta	-0.09
RSI	48.28
Earnings Date	Aug 14, 2025

About Theseus Pharmaceuticals

KOP Limited, an investment holding company, operates as a real estate development company in Singapore, Indonesia, and the United Kingdom. The company operates through Real Estate Development and Investment; Real Estate Origination and Management Services; and Hospitality segments. It is also involved in the properties acquisition and development conceptualization, construction management, and marketing and branding strategizing activities, as well as retail sale of projects; and development, management, and operation of hotels and resorts, inc...

• Industry: Motion Picture and Video Tape Distribution
• Founded: 2004
• Employees: 50
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 5I1

Financial Performance

In 2024, KOP Limited's revenue was 69.68 million, a decrease of -13.68% compared to the previous year's 80.72 million. Losses were -1.18 million, -59.84% less than in 2023.